
News
from the fight to #SaveIndiePharmacy
New York Times’ The Middlemen series

Pharmacy benefit managers: What journalists need to know about the prescription drug middleman industry
It may sound counterintuitive, but firms that were created to negotiate better deals for consumers on medicines instead have sometimes driven up the costs of prescriptions — while also putting the survival of community pharmacies at risk.
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.